Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Document Security Systems, Inc.
ROCHESTER, N.Y., Oct. 22, 2013 /PRNewswire/ -- Document Security Systems, Inc. (NYSE MKT: DSS; "DSS"), a leading developer and integrator of secure cloud computing and security printing technologies, today announced a partnership with the National Association of Drug Diversion Investigators (NADDI) to help NADDI's members and consumers combat drug diversion and counterfeits.
NADDI is a non-profit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of prescription drug diversion. NADDI's objective is to improve its members' ability to investigate and prosecute pharmaceutical drug diversion.
This partnership provides NADDI members access to DSS's AuthentiSuite technologies as part of an initiative to standardize prescription drug authentication for members and customers. NADDI members have never before had access to this type of authentication capability. The AuthentiSite technology can be employed as a tool for investigators or consumers who are looking to verify websites for prescription drug purchases and validate that pharmaceutical product information, lists of authorized suppliers, and other online information comes from the Brand Owner and not an unauthorized or fraudulent source.
AuthentiSite provides true website authentication from a smartphone application. The DSS team will create and distribute an AuthentiSite seal equipped with DSS patented AuthentiGuard® PrismTM technology for NADDI and its members to implement on their websites. Using the smartphone application, investigators and consumers alike can scan the seal to verify that a website represents a true, licensed reseller.
Robert Bzdick, President of DSS stated, "We are pleased to be working with NADDI, the nation's most prominent organization linking healthcare regulators, manufacturers and consumers, to offer its members access to our AuthentiSite technology in order to combat drug diversion. This partnership brings the powerhouse of AuthentiSuite technologies into the pharmaceutical world, while opening up future opportunities to build business relationships in this area."
DSS will be attending NADDI's 24th Annual Conference on November 19th - The Challenges of Prescription Drug Abuse, Diversion and Counterfeiting for the Community, Law Enforcement and Industry - The Issues and the Fight Back – to discuss the growing number of possibilities AuthentiSite offers.
Charlie Cichon, NADDI Executive Director stated, "We welcome the partnership with DSS and the extraordinary technology of AuthentiSuite, not only at our 24th Annual Conference in St. Louis, but also through the RxAuthentic link that our members and consumers can access on the NADDI website – www.naddi.org."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
About DSS (Document Security Systems, Inc.)
Document Security Systems, Inc.'s (NYSE MKT: DSS) products and solutions are used by governments, corporations and financial institutions to defeat fraud and to protect brands and digital information from the expanding world-wide counterfeiting problem.
DSS continually invests in technology to meet the ever-changing security needs of its clients and implements these patented solutions through the Company's operating groups.
Effective July 1, 2013, Lexington Technology Group, Inc., now known as DSS Technology Management ("DSS TM") became a wholly-owned subsidiary of Document Security Systems, Inc. ("DSS" or "Company"). DSS TM provides strategy for DSS's IP portfolio, as well as legal expertise and investment capital for pioneering inventions.
DSS provides counterfeit deterrence and authentication technology coupled with licensing and IP monetization solutions. When implemented, DSS technologies help ensure the authenticity of both digital and physical financial instruments, identification documents, sensitive publications, brand packaging and websites.
For more information on the AuthentiGuard Suite, please visit www.AuthentiGuard.com
For more information on DSS and its subsidiaries, please visit www.DSSsecure.com.
Follow DSS on Facebook, click HERE.
For more information:
Document Security Systems
Document Security Systems
Forward Looking Statements
Forward-looking statements that may be contained in this press release, including, without limitation, statements related to the Company's plans, strategies, objectives, expectations, potential value, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act and contain words such as "believes", "anticipates", "expects", "plans", "intends" and similar words and phrases. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the results projected in any forward-looking statement. In addition to the factors specifically noted in the forward-looking statements, other important factors, risks and uncertainties that could result in those differences include, but are not limited to, those disclosed in the "Risk Factors" section of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, filed with the Securities and Exchange Commission on August 13, 2013. Forward-looking statements that may be contained in this press release are being made as of the date of its release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements.
©2012 PR Newswire. All Rights Reserved.